Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide and Radiation in NSCLC Brain Metastasis
NCT00080938Phase 2Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Dec 2005
- Primary completion
- Aug 2008
01
Overview
Phase 2, open-label trial of temozolomide in non-small cell lung cancer (NSCLC) and brain metastasis (BM), sponsored by Eastern Cooperative Oncology Group. Primary endpoint: Intracranial Response Rate at 2 years. Started Dec 2005; status: completed.
02
Drugs
temozolomide
03
Conditions
non-small cell lung cancer (NSCLC)brain metastasis (BM)
Beyond the preview
Go deeper on NCT00080938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00080938.